Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
Status:
Completed
Trial end date:
2014-10-24
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate the
pharmacokinetics (the exposure of the trial drug in the body), safety and tolerability of
oral semaglutide in subjects with various degrees of impaired renal function compared to
subjects with normal renal function.